Witness Testimony

Dr. Peter McCullough provided virtual testimony discussing a systematic review of 44 published autopsy studies comprising 324 cases of deaths following COVID-19 vaccination. He stated that three independent pathology reviewers assessed causality and concluded that approximately 73.9% of cases involved the vaccine as a direct or contributing factor, most commonly myocarditis and cardiovascular causes occurring within 30 days of injection. He also described the paper’s temporary posting on a Lancet preprint server and subsequent removal, as well as concerns about limited autopsy performance during the pandemic.
He further testified regarding pregnancy and reproductive safety, stating that pregnant and breastfeeding women were excluded from initial clinical trials yet later encouraged to receive vaccination. He referenced maternal mortality data, VAERS analyses comparing COVID-19 vaccines to influenza vaccines, and studies he interpreted as indicating increased risks of miscarriage, stillbirth, maternal hemorrhage, menstrual irregularities, and reduced sperm parameters. He asserted that natural infection outcomes and early treatment options reduced justification for vaccination in pregnant populations.
Dr. McCullough also criticized the integrity of the original Pfizer clinical trial, calling for regulatory audits and alleging protocol breaches. He described a range of reported adverse events including myocarditis, thrombosis, neurologic syndromes, and autoimmune conditions, attributing many effects to spike protein toxicity and persistence. He raised concerns about manufacturing contamination with DNA fragments and potential cancer-promoting mechanisms. As a proposed mitigation strategy, he described an empiric protocol involving nattokinase, bromelain, and curcumin aimed at degrading spike protein, while acknowledging the absence of large randomized trials.